Dose modifications of ribociclib and endocrine therapy for treatment of ER+ HER2- metastatic breast cancer. Kristensen KB, Thomsen IMN, Berg T, Kodahl AR, et al. Breast Cancer Res Treat 2021 Apr 10. pii: 10.1007/s10549-021-06215.

Read + Share

Amedeo Smart

Independent Medical Education

Kristensen KB, Thomsen IMN, Berg T, Kodahl AR, et al. Dose modifications of ribociclib and endocrine therapy for treatment of ER+ HER2- metastatic breast cancer. Breast Cancer Res Treat 2021 Apr 10. pii: 10.1007/s10549-021-06215.
PMID: 33837869